Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy.

Zoberi, Jacqueline E; Garcia-Ramirez, Jose; Luechtefeld, David; Maughan, Nichole M; Amurao, Maxwell; Oyama, Reiko; Baumann, Brian C; Gay, Hiram A; Michalski, Jeff M

Zoberi, Jacqueline E; Garcia-Ramirez, Jose; Luechtefeld, David; Maughan, Nichole M; Amurao, Maxwell; Oyama, Reiko; Baumann, Brian C; Gay, Hiram A; Michalski, Jeff M.

Afiliação

Zoberi JE; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Garcia-Ramirez J; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Luechtefeld D; Environmental Health and Safety, Washington University School of Medicine, Saint Louis, Missouri, USA.
Maughan NM; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Amurao M; Environmental Health and Safety, Washington University School of Medicine, Saint Louis, Missouri, USA.
Oyama R; MIR Cyclotron Facility and Nuclear Pharmacy, Washington University School of Medicine, Saint Louis, Missouri, USA.
Baumann BC; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Gay HA; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, Missouri, USA.
Michalski JM; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, Missouri, USA.

J Appl Clin Med Phys ; 24(4): e13899, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36637862

Assuntos

Lutécio; Neoplasias de Próstata Resistentes à Castração; Compostos Radiofarmacêuticos; Humanos; Masculino; Lutécio/uso terapêutico; Próstata; Antígeno Prostático Específico; Neoplasias de Próstata Resistentes à Castração/radioterapia; Neoplasias de Próstata Resistentes à Castração/tratamento farmacológico; Neoplasias de Próstata Resistentes à Castração/metabolismo; Compostos Radiofarmacêuticos/uso terapêutico; Resultado do Tratamento

Palavras-chave

QA/QC; commissioning; radiopharmaceutical therapy; safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Neoplasias de Próstata Resistentes à Castração / Lutécio Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google